Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LOPERAMIDE Cause Ejection fraction decreased? 24 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Ejection fraction decreased have been filed in association with LOPERAMIDE (Anti-diarrheal). This represents 0.1% of all adverse event reports for LOPERAMIDE.

24
Reports of Ejection fraction decreased with LOPERAMIDE
0.1%
of all LOPERAMIDE reports
4
Deaths
21
Hospitalizations

How Dangerous Is Ejection fraction decreased From LOPERAMIDE?

Of the 24 reports, 4 (16.7%) resulted in death, 21 (87.5%) required hospitalization, and 13 (54.2%) were considered life-threatening.

Is Ejection fraction decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LOPERAMIDE. However, 24 reports have been filed with the FAERS database.

What Other Side Effects Does LOPERAMIDE Cause?

Drug ineffective (3,207) Diarrhoea (1,909) Constipation (1,614) Off label use (1,378) Incorrect dose administered (1,178) Drug abuse (1,088) Nausea (997) Intentional product use issue (871) Overdose (857) Toxicity to various agents (753)

What Other Drugs Cause Ejection fraction decreased?

SACUBITRIL\VALSARTAN (2,551) TRASTUZUMAB (1,579) DOXORUBICIN (834) CYCLOPHOSPHAMIDE (754) PERTUZUMAB (644) DOCETAXEL (520) PACLITAXEL (466) BISOPROLOL (314) RITUXIMAB (296) CARVEDILOL (284)

Which LOPERAMIDE Alternatives Have Lower Ejection fraction decreased Risk?

LOPERAMIDE vs LOPINAVIR LOPERAMIDE vs LOPINAVIR\RITONAVIR LOPERAMIDE vs LOPRAZOLAM LOPERAMIDE vs LORATADINE LOPERAMIDE vs LORATADINE\PSEUDOEPHEDRINE

Related Pages

LOPERAMIDE Full Profile All Ejection fraction decreased Reports All Drugs Causing Ejection fraction decreased LOPERAMIDE Demographics